Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Brawn Laboratories Limited
Location
People
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
Network
T. Score
Registered Details

BRAWN LABORATORIES LIMITED

All Companies ›

Delhi ›

Research & Development ›

Active

Updated: 15 Jun 2026

Brawn Laboratories Limited provides pharmaceutical products

Brawn Laboratories Limited, is an unlisted public company incorporated on 27 March, 1990. It is classified as a public limited company and is located in , Delhi. It's authorized share capital is INR 1.00 cr and the total paid-up capital is INR 99.50 lac.

Subscription Plans

Industry and products

Research and Development

Dry Powder Injections, Liquids, Cephalosporin and Penicillin products. It manufactures a wide variety of dosage forms to include Tablets, Non Beta, Eye Ear drops, Creams, Ointments & Gels, Liquid Injections in vials & ampoules, Pre filled syringes and others., Lyophillized Injections, Capsules, Dry Syrups

Company size

Auth Capital

₹ 1.0 Cr

Paidup Capital

₹ 99.5 L

Revenue

₹ 300-400 cr

Key Metrics

** All rupee values in INR crores.

Total Revenue

-1.58%

₹ GET PRO

EBITDA

12.55%

₹ GET PRO

Net Profit

-13.54%

₹ GET PRO

Networth

20.75%

₹ GET PRO

Borrowings

780.66%

₹ GET PRO

Assets

19.93%

₹ GET PRO

Gross Margin

-3.33

GET PRO %

Operating Margin

1.6

GET PRO %

Net Profit Margin

-1.33

GET PRO %

Return on Equity

-6.81

GET PRO %

ROCE

-1.25

GET PRO %

Debt to Equity

0.13

GET PRO

Sales

Mar 2024

Net worth

Mar 2024

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

Buy credits

View subscriptions

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
Financial+Litigation report

₹ 1299
- Everything in financial report
- Litigation report on the company
Due diligence report

₹ 2999
- Everything in financial+litigation report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

Locations

India (18)

State	Type	Address

Locations on Map

People

Designation	Name	DIN/PAN	Tenure
Director	Brij Raj Gupta Shareholder	00974969	23 years
Director	Ankit Goyal	10071062	3 years
Director	Mayank Jain	07993851	2 years
Director	Pooja Jha	10749145	2 years

Financial Highlights

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

** All numbers in INR crores

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2017	Mar 2018	Mar 2022	Mar 2023	Mar 2024
Equity Capital	1.0	1.0	1.0	1.0	1.0
Reserves	27.3	40.2	111.7	147.1	175.9
Borrowings +	17.7	8.6	2.0	3.1	27.5
Long term borrowings	4.9	2.2	1.9	3.0	2.5
Short term borrowings	12.8	6.4	0.1	0.1	25.0
Trade payables +	13.4	16.2	23.0	12.0	16.9
Days payable	38.0	56.0	56.0	26.0	35.0
Other liabilities +	24.8	53.9	53.6	76.1	64.3
Other non-current liabilities	2.7	2.5	3.1	2.3	3.0
Other current liabilities	22.1	51.4	50.5	73.7	61.3
Total liabilities	84.2	120.0	191.3	239.3	285.6
Fixed Assets +	22.4	24.5	37.9	51.4	62.8
Tangible assets	21.9	24.0	31.4	39.7	40.8
CWIP	0.5	0.5	6.5	11.7	22.0
Intangible assets	-	-	-	-	-
LT loans and advances	0.3	0.7	-	-	-
Other non-current assets	-	-	-	16.0	20.9
Current assets +	61.5	94.7	153.4	171.9	201.9
Inventories	14.2	12.2	23.3	22.7	14.0
Trade receivables	40.0	67.0	66.4	62.2	116.0
Cash and cash equivalents	1.9	2.7	21.2	38.6	22.4
ST loans and advances	5.2	12.7	39.5	44.8	45.2
Other current assets	0.2	0.2	3.1	3.6	4.3
Total assets	84.2	120.0	191.3	239.3	285.6

Percentage of assets	Mar 2017	Mar 2018	Mar 2022	Mar 2023	Mar 2024
Equity Capital	1.18	0.83	0.52	0.42	0.35
Reserves	32.44	33.55	58.4	61.47	61.59
Borrowings +	21.06	7.18	1.04	1.3	9.62
Long term borrowings	5.82	1.85	0.98	1.26	0.86
Short term borrowings	15.23	5.33	0.06	0.04	8.75
Trade payables	15.88	13.52	12.01	5.02	5.93
Other liabilities +	45.32	58.44	40.05	36.81	28.44
Other non-current liabilities	3.25	2.06	1.62	0.98	1.07
Other current liabilities	26.19	42.86	26.42	30.81	21.45
Total liabilities
Fixed Assets +	26.59	20.45	19.79	21.48	21.99
Tangible assets	25.99	20.03	16.42	16.61	14.29
CWIP	0.6	0.42	3.38	4.87	7.7
Intangible assets	0.0	0.0	0.0	0.0	0.0
LT loans and advances	0.41	0.57	0.0	0.0	0.0
Other non-current assets	0.04	0.0	0.0	6.68	7.3
Current assets +	72.96	78.98	80.21	71.84	70.71
Inventories	16.86	10.13	12.16	9.5	4.91
Trade receivables	47.52	55.88	34.73	25.99	40.61
Cash and cash equivalents	2.27	2.22	11.06	16.15	7.83
ST loans and advances	6.12	10.57	20.64	18.71	15.84
Other current assets	0.19	0.18	1.62	1.5	1.5
Total assets

Total assets

Charges on assets

Bank wise

Charges

CitiBank N.A.

No. of Loans: 2

Total Amount : 200.0 cr

HDFC Bank Limited

No. of Loans: 1

Total Amount : 115.0 cr

Punjab National Bank

No. of Loans: 4

Total Amount : 80.5 cr

Charge Holder	Amount	Date of creation/modification
Punjab National Bank	0.1 cr	05 Jul, 2025
CitiBank N.A.	150.0 cr	30 Jan, 2025
HDFC Bank Limited	115.0 cr	23 Jan, 2025
Punjab National Bank	0.3 cr	09 Jan, 2025
Punjab National Bank	0.1 cr	13 Dec, 2024
Punjab National Bank	80.0 cr	16 Nov, 2024
CitiBank N.A.	50.0 cr	20 May, 2023

Charges

CitiBank N.A.

HDFC Bank Limited

Punjab National Bank

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
OVERSEAS LABORATORIES PRIVATE LIMITED	Strike Off	1.0 L	1	Delhi
A B PHARMA PRIVATE LIMITED	Strike Off	7.3 L	1	Delhi
BRAWN COSMETICS AND HERBALS PRIVATE LIMITED	Active	10.0 L	1
BRAWN BIOTECH LIMITED	Active	3.0 Cr	3	Delhi
CONSULT AVENUE PRIVATE LIMITED	Active	2,000.0	1	Delhi
AM2PM SUPPORT PRIVATE LIMITED	Active	10.0 L	1	Delhi
GO VALUE FINANCIAL SERVICES PRIVATE LIMITED	Active	1.0 L	1	Delhi

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
Shashi Medicare Inc.	United States	-	-

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

CIN

U73200DL1990PLC039653

PAN

AAACB7151N

Incorporation

1990, 36.3 years

Company Email

solution@brawnbiotech.com

Paid up Capital

₹ 99.5 L

Authorised Capital

₹ 1.0 Cr

AGM

Sep 2024

Type

Public

Others

FAQ - BRAWN LABORATORIES LIMITED

What is the incorporation date of BRAWN LABORATORIES LIMITED?

The incorporation date of BRAWN LABORATORIES LIMITED is 27 March, 1990

What is the authorized share capital of BRAWN LABORATORIES LIMITED?

The authorized share capital of BRAWN LABORATORIES LIMITED is INR ₹ 1.0 Cr.

What is the paid-up capital of BRAWN LABORATORIES LIMITED?

The paid-up capital of BRAWN LABORATORIES LIMITED is INR ₹ 99.5 L.

What is the registered address of BRAWN LABORATORIES LIMITED?

The registered address of BRAWN LABORATORIES LIMITED is C-64 LAJPAT NAGAR - 1, SECOND FLOOR NEW DELHI, South Delhi, DELHI, Delhi, India, 110024 - 110024

What is the CIN number of BRAWN LABORATORIES LIMITED?

The CIN number of BRAWN LABORATORIES LIMITED is U73200DL1990PLC039653.

Smart Suggestions

Top Blog Post

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

BRAWN LABORATORIES LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Buy Report or Plans

Dashboards

Company dashboard

Buy credits

View subscriptions

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Financial+Litigation report

Due diligence report

Choose number of credits to buy

₹ 449 + GST

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

People

Financial Highlights

Margins

Balance Sheet

Total assets

Charges on assets

Charges

Company Network